US2002187499A1PendingUtilityA1

Use of cathepsin S in the diagnosis and treatment of endometriosis

Priority: Jun 4, 1998Filed: Mar 13, 2002Published: Dec 12, 2002
Est. expiryJun 4, 2018(expired)· nominal 20-yr term from priority
C12Q 2600/158G01N 2800/364C12Q 1/6883G01N 33/68G01N 2333/96466A61P 15/00G01N 33/5755
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Cathepsin S expression is up-regulated in embodmetriotic tissue. This invention provides methods of diagnosing endometriosis by detecting up-regulation of a cathepsin S gene product, and methods of treating endometriosis by down-regulating expression of cathepsin S in ectopic or ectopic endometriotic tissue.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A kit comprising a compound that binds a cathepsin S gene product and instructions to (1) use the compound for detecting cathepsin S in a patient sample, and (2) to diagnose endometriosis based on an elevated amount of the cathepsin S gene produce in the sample compared with a normal amount of cathepsin S.  
     
     
         2 . The kit of  claim 1  wherein the cathepsin S gene product is cathepsin S mRNA or cDNA and the compound is a polynucleotide that hybridizes with cathepsin S mRNA or cDNA under stringent conditions.  
     
     
         3 . The kit of  claim 1  wherein the cathepsin S gene product is cathepsin S polypeptide and the compound is an antibody that specifically binds to cathepsin S polypeptide.

Join the waitlist — get patent alerts

Track US2002187499A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.